Acquisitions of U.S. Pharmaceutical/Health Care Companies: A Health Regulatory Focus
U.S. pharmaceutical, health care and other life sciences companies are increasingly seen as potential targets of acquisition, not only by stronger domestic competitors, but also by overseas rivals in Japan in particular. The relatively weak dollar and increased downside risk from the current global financial crisis have made U.S. firms attractive buys. Our industry experts examine recent industry deals involving Japanese firms and share demographic insights into the future of the U.S. health care industry. They identify high risk topics for pharmaceutical firms in health regulatory due diligence and discuss recent federal health care legislative activities that will affect M&A activities in the U.S. health care industry.
Wendy Goldstein, Member of the Firm; Pharmaceutical Practice Group Leader, Epstein Becker & Green P.C.
Scott Minars, Partner, Merger & Acquisition Services, Deloitte & Touche LLP
Lynn Shapiro Snyder, Member of the Firm; Co-Chair, Health Care Fraud Practice Group; Chair, Third Party Payment Practice Group, Epstein Becker & Green P.C.
Michael Levine, Member of the Firm; Head of CSR/Sustainability Practice, Epstein Becker & Green P.C.
12-12:30 pm Registration & reception
1-2:30 Panel discussion & audience Q&A
Admission: Corporate members are entitled to a designated number of free admissions to this event, based on their company’s current membership level. These reservations must be made at least 48 hours prior to the event. Additional corporate registrants and Japan Society individual members at the Patron Circle level and above pay the discounted corporate member rate of $45 for lunch and lecture, $10 for lecture only. Nonmember admission: $65 for lunch and lecture, $15 lecture only. The academic and government admission rate is $30 for the luncheon and $10 for lecture only. When payment is required, prepayment must be made, or registration secured, with a credit card. All registrations and cancellations must be made at least 48 hours prior to the event. Substitutions are welcome.
For information only, please contact the Corporate Program at 212-715-1208.
- May 21, 2009 at 12:00 pm